CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 118 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 3.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,496,320 | +65.4% | 128,000 | +90.2% | 0.02% | +66.7% |
| Q2 2023 | $904,512 | +22.3% | 67,300 | +50.9% | 0.01% | +12.5% |
| Q1 2023 | $739,468 | +23.9% | 44,600 | +38.9% | 0.01% | +33.3% |
| Q4 2022 | $597,060 | -22.2% | 32,100 | -46.3% | 0.01% | -33.3% |
| Q3 2022 | $767,234 | -45.2% | 59,800 | -64.6% | 0.01% | -30.8% |
| Q1 2022 | $1,399,000 | +157.6% | 168,700 | +110.3% | 0.01% | +225.0% |
| Q4 2021 | $543,000 | +10.6% | 80,200 | -13.4% | 0.00% | -20.0% |
| Q3 2021 | $491,000 | -9.2% | 92,600 | -1.6% | 0.01% | 0.0% |
| Q2 2021 | $541,000 | +73.4% | 94,100 | +39.2% | 0.01% | +66.7% |
| Q1 2021 | $312,000 | +32.2% | 67,600 | -4.2% | 0.00% | +50.0% |
| Q4 2020 | $236,000 | +46.6% | 70,600 | +30.5% | 0.00% | 0.0% |
| Q3 2020 | $161,000 | -49.5% | 54,100 | -21.7% | 0.00% | -50.0% |
| Q2 2020 | $319,000 | +198.1% | 69,100 | +149.5% | 0.00% | +300.0% |
| Q1 2020 | $107,000 | +0.9% | 27,700 | -2.1% | 0.00% | 0.0% |
| Q4 2019 | $106,000 | -43.3% | 28,300 | -19.8% | 0.00% | -50.0% |
| Q3 2019 | $187,000 | – | 35,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,517,885 | $22,789,000 | 2.29% |
| March Altus Capital Management LP | 80,890 | $334,000 | 1.94% |
| TANAKA CAPITAL MANAGEMENT INC | 111,693 | $462,000 | 1.15% |
| PURA VIDA INVESTMENTS, LLC | 395,000 | $1,951,000 | 1.00% |
| Broadfin Capital, LLC | 4,183,177 | $17,277,000 | 0.93% |
| Catalyst Capital Advisors LLC | 1,310,000 | $5,411,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,200,000 | $4,956,000 | 0.48% |
| Baker Brothers Advisors | 7,335,692 | $30,296,000 | 0.27% |
| TURNER INVESTMENTS LLC | 286,370 | $1,183,000 | 0.22% |
| Perceptive Advisors | 851,200 | $3,515,000 | 0.21% |